Women s Health. Obstacles & Opportunities

Similar documents
VMS across the Globe. In- depth view of the World s OTC VMS Markets. Australia Brazil Canada China France Germany India Indonesia Italy

OTC Dermatologicals A Nicholas Hall report on the Global OTC Derma market

OTC YEARBOOK. Full-year sales data to end-2017 from DB6 Global OTC Database THE ESSENTIAL GUIDE IN TODAY S CHALLENGING MARKETS

HEALTHY AGEING The Expanding OTC Market for 50+ Consumers

Nicholas Hall s Global OTC Markets The Definitive Guide to the World s 12 Leading OTC Markets

ROAD TO RIO: LAND OF OTC OPPORTUNITIES NICHOLAS HALL S LATIN AMERICAN OTC CONFERENCE 2014

ALM & Balance Sheet Optimisation 2017

DB6 GLOBAL OTC DATABASE

MERCK KGAA, DARMSTADT, GERMANY

Medical Alert Systems/Personal Emergency Response System (PERS) Market by Type (Landline PERS, Mobile PERS (MPERS), Standalone PERS), by End- User

H E A L T H C A R E. Future trends, emerging opportunities and key players. Report Price Publication date. $3835 April 2010

ENTRY INFORMATION PACK

Discover the latest value-enhancing and risk-minimising opportunities for the European indexing and ETF industry

16 th edition of this popular report

Accelerating our IPT strategy

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC FORM 8-K

London Stock Exchange Group plc (LSE) - Financial and Strategic SWOT Analysis Review

Thank you for downloading this information.

The Health Plan has processes in place that explain how members, pharmacists, and physicians:

European Gas Trading 2018

MARCH VALUE OF OTC MEDICINES. to the U.S. Healthcare System

Willow Bend OB/GYN Obstetrics, Gynecology & Infertility

NEW PATIENT REGISTRATION

This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as stat

2017 CDB Pharmaceutical and Health. Sciences Compensation Surveys - U.S.

Aligning regulatory incentives for innovation in the consumer health products industry

J.P. Morgan Healthcare Conference

ACCA Charity Finance Conference Tuesday 10 October Jurys Inn, Birmingham

WESLEYAN PROVIDES HELP WHEN YOU NEED IT MOST INCOME PROTECTION FOR STUDENT AND FOUNDATION DENTISTS

Claims: A Consumer s Perspective. Pacific Life Re 2018 UK consumer research

PATIENT INFORMATION NAME SOCIAL SECURITY BIRTH DATE ADDRESS CITY STATE ZIP CODE

Personal Accident and Health Insurance in India, Key Trends and Opportunities to 2018

Claims: A Consumer s Perspective

2017 Vitality Engagement Study

Small Business Package. Growing your ambition

2018 J.P. Morgan Healthcare Conference January 9, 2018

ConvaTec Healthcare B Sarl - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adjustable Rate Allowance. And Product Disposition Policy

Car insurance price index. The most comprehensive analysis of car insurance pricing in the UK

(Formerly AFCN Physical Medicine) A member of the Arkansas Family Care Network, P.A.

Global Telemedicine Market Outlook 2022

5 JUNE HILTON PRAGUE HOTEL, PRAGUE

Fund Guide. Short Duration Credit Fund

Meritus Digestive Health Specialists

FINANCIAL INFORMATION IN BRIEF

PATIENT INTAKE AND MEDICAL INFORMATION

Consent Release Form for Medical Information

Insurance Inside Super. A detailed report into members awareness, attitudes and engagement with Insurance Inside Super.

Synta Pharmaceuticals Corp (SNTA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

AIC Generalist Sectors

OUR TERMS OF BUSINESS AND COMMITMENT TO YOU

Healthcare Freedom is Finally Available

Card Protection Metrics: Consumer Approaches to Card Protection Insurance in Europe

British Virgin Islands

Canadians opinions on the impact of international trade agreements on the Canadian economy Nanos Trade Survey Summary

Patient Registration Form

Shadow Billing Ends October 31 for IRIS Non-Compliance Penalty Assessment Program

AMP CAPITAL BLACK SKY REPORT 2017

Profession Are you retired? Yes No. Are you registered? Yes. Degree/Qualification Academic Institution Minimum Duration of Degree/Qualification

Male. Female. Marital Status: ID/Passport No.: Mobile:

Brevard Public Schools Medical Plan Options & Resources

Version: 2. Date adopted: Review date: April Expiry date: 1 January Target audience: All LPT Staff

AFL/Cricket Australia Synthetic Turf Product Certification PROGRAM OVERVIEW

PATIENT INFORMATION FORM

Chemical Biological Radiological Nuclear and Explosives (CBRNE) Detection Equipment Market - By System (Radiation Detectors, Spectrometers,

INVESTOR FOCUSED. WE CONNECT PEOPLE, DATA AND INSIGHTS.

The Life Protector Plan

MANAGE RISK WORLDWIDE

Apparel Retail in Switzerland

LPF TRUSTS MEDICAL SCHEME TERMS AND CONDITIONS

NAME AND PHONE NUMBER OF PHARMACY:

Landis+Gyr plans IPO and listing on SIX Swiss Exchange

IMS Retail Drug Monitor

NEBOSH HSE. Training. Certificate in Process Safety Management. Trainer : Andrew Gibbins. 16 th - 20 th April,2018 Angola

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi

The Heidrick & Struggles Board Monitor Europe

MyHEALTH INDIVIDUAL MEDICAL PLANS

Building the leading company in health and well-being

Value of Consumer Health Products: The Impact of Switching Prescription Medications to Over-the-Counter

Annual General Meeting July 20, 2017

GROUP INCOME PROTECTION.

Investment Funds and Asset Management in Poland,

TOPLINE REPORTS TOTAL U.S. DRUG CHAINS

NIKE, INC. REPORTS FISCAL 2018 FOURTH QUARTER AND FULL YEAR RESULTS

Patient Information. State Zip Home Phone Cell Phone

AIA Vitality Adviser FAQs

Sick Pay CONTENTS. Group Protection TERMS AND CONDITIONS. Section A Interpretation Interpretation...2

NPS Benchmarking. Proposals for our bi-annual multi-client research programme. Issued : 29 th July Respond by: 22 nd August 2014

Basware grew SaaS revenues by 99% and continued to invest in enablers for the 2018 strategy

Patient Name: Date of Birth: Last name, First Name. Address: Street, City, State, Zip. Cell Phone: Home Phone: Work Phone:

PATIENT INFORMATION. Patient Name: Address: City: State: Zip: Home Phone: ( ) Cell: ( ) Age: Date of Birth:

Commonwealth Business Forum

RiverCity Women s Health, PLLC

Allianz EFU Health Insurance Limited Window Takaful Operations

H A L F Y E A R R E S U L T S 30 th June P r e s e n t a t i o n of Mr. C h r i s t i a n M U L L I E Z

Simavita Australian investor briefing presentation

MK-Bathrooms.net Terms & Conditions of Sale

Application Form Multi Currency Account (EUR USD RMB)

Skills Framework for the Information Age General terms and conditions for licences Issued on 26 th August 2016 by SFIA Foundation ( The Foundation )

Reinvigorating Our Leading OTC Position

Transcription:

Women s Health Obstacles & Opportunities

Women s Health Obstacles & Opportunities Built on the back of over 35 years experience in the OTC industry, Nicholas Hall updates its successful Women s Health report, taking a new look at this key consumer group. While women are often stereotyped as proactive health-seekers, in truth the OTC women s health category has significant areas of untapped potential. Undertreating is a key concern, with many common conditions such as overactive bladder and menopausal symptoms simply endured rather than addressed. OTC marketers need to engage more effectively with women and convey the message that efficacious OTC options are available. Women s Health: Obstacles & Opportunities investigates the problems and possibilities present in this category. It analyses the current market for a range of OTC options, considering products positioned for gender-specific concerns as well as more general ailments that disproportionately affect women. Featuring OTC sales data from DB6, Nicholas Hall s Global OTC Database, the report profiles key areas including intimate & sexual health, age-related concerns and pregnancy & motherhood. It also examines the numerous opportunities within women s health, considering established areas and potential new developments, such as the ongoing discussions in relation to OTC availability of daily oral contraception in Western markets. Many OTC marketers recognise women s health as a gateway to growth, but untapped OTC opportunities abound. Discover the key to unlocking the market s potential and sidestepping the obstacles in this comprehensive report. Nicholas Hall, Chairman & CEO, Nicholas Hall Group of Companies

CHAPTER SUMMARIES Prevalent Female Concerns IBS remedies Migraine Laxatives Weight management Health maintenance Cosmetic Concerns Acne remedies Beauty supplements Intimate & Sexual Health Urinary Tract Infection Vaginal Yeast Infection Feminine Intimate Care Sexually Transmitted Diseases Contraception Pregnancy & Motherhood Family planning Pregnancy Menstruation Period pain PMS Age-related Concerns Menopause Joint health Osteoporosis Overactive bladder Brain health Key Questions Answered KEY FEATURES OTC sales to mid-2014 from Nicholas Hall s Global OTC Database DB6, where available, plus historic data back to 2009 What impact has been Overviews made so far of latest by the studies numerous relevant PPI to women s health launches around the globe? Can Nexium be a success in the US, Europe and Australia Each following category switch? supported with key brand profiles Which strategies will marketers of brands adopt in countries where private labels and generics hinder growth? Can GIs maintain their booming KEY sales QUESTIONS in Russia relying ADDRESSED on a combination of price rises and high levels of A+P support? Are marketers effectively targeting women? How have changing lifestyle habits and increased consumer education contributed to Will strong switch growth drive in developments Asia-Pacific? in women s health? What launches and line extensions Are there have untapped been the areas main of opportunity? growth drivers in Latin America? Which brands have got the strategy right and what can be learnt? How will changing consumer demands alter marketers strategies? What are the major trends & developments driving sales in individual women s healthcare categories?

in collaboration with: Nicholas Hall & Company offers the world s most complete OTC marketing & business solutions Dedicated to benchmarking consumer healthcare markets and providing business solutions, we are specialists in OTC, with an international network of contacts, offering data & analysis, strategic advice and competitive intelligence on a global, regional or local basis. Other Nicholas Hall Reports: Nicholas Hall s OTC YearBook 2015 Nicholas Hall s best-selling unique reference book contains comprehensive market data through December 2014 from our global OTC sales database DB6, covering every major industry development. Publishing in April 2015 Global OTC Gastrointestinals Shining a spotlight on the global GIs market, this publication provides detailed reporting and vital insight into individual categories and brands, based on sales to mid-2014 from Nicholas Hall s Global OTC Database DB6. Publishing in February 2014 Lifestyle OTCs This report looks at the current market situation, taking in regulatory developments, marketers & brand activity, launches and A+P campaigns. It shows how emerging lifestyle trends impact core OTC categories such as pain, cough & cold, GIs and VMS. Published in December 2014 Successful OTC Brands series Our Successful OTC Brands series offers case studies into the most successful brands from across the OTC industry. The two reports offer analysis on how A+P support (including social media), product innovation and positioning helped these brands achieve success. Published in October 2014 Global OTC Dermatologicals This essential guide to the global derma market breaks down categories country by country, supported with brand cases studies and full-year 2013 sales data from Nicholas Hall s Global OTC Database DB6. Published in September 2014 AN UNTAPPED OTC MARKET Men s Heath: An Untapped OTC Market This report investigates the options available to OTC marketers, considering men s health in context, the current OTC areas of particular relevance to men and how switch can expand the men s OTC market. Published in July 2014 OTC Marketers of the Moment This report examines some of the biggest and most promising players in the OTC market today. In-depth profiles feature facts, data and analysis, giving readers a full picture of where the companies stand and where they are headed. Published in May 2014 Register Online - Nicholas Hall Reports: To be notified about all our upcoming reports and OTC events, please join our mailing list on our website at www.nicholashall.com or email us your details (full name, company, job title, email and telephone number) at info@nicholashall.com with subject Report Notification. Nicholas Hall & Company 35 Alexandra Street, Southend-on-Sea, SS1 1BW, UK E: info@nicholashall.com W: www.nicholashall.com Connect with us: Scan with your Smartphone

Women s Health 20+ categories covered 40+ brands profiled Future prospects for each category, with sales forecasts where available Save up to GB 1,500 on early orders 5% discount on payments by credit card Published in PDF format Quick delivery Versatile format

PRIORITY ORDER FORM FOR Women s Health REPORT A global licence will be required if you wish to put this report on your company s intranet. All prices are quoted in British Pounds Sterling. Please tick as appropriate. I would like to order: If ordered before 13th March Orders at full rate after 13th March Global Licence 8,500 10,000 Country Licence 6,545 7,700 DELIVERY DETAILS Mr/Mrs/Ms/Dr/Other Last Name Job Title Company Address Country Tel Email First Name Post/zip code Fax PAYMENT DETAILS Please invoice my company quoting order no/ref: (material will be sent when full payment is received) I claim 5% discount for payment by credit card. Please debit my Visa American Express Other Card no: Expiry date: Security code (not needed for Amex) VAT ID Number (EU only): Card billing address (if different from above) Post/Zip Code Signed: Date: DD / MM / YYYY If you do not wish to receive future information from us, please tick as appropriate: Mail Fax Email Please fax the completed order form to +44 (0) 1702 220 241 or email to info@nicholashall.com. Nicholas Hall & Company 35 Alexandra Street, Southend-on-Sea, Essex, SS1 1BW, UK T: +44 (0) 1702 220 200 F: +44 (0) 1702 430 787 E: info@nicholashall.com W: www.nicholashall.com